Botulinum toxin Articles from SENIORFITNESS.COM Free Article Directory


Subject Directory
Find your Specific Interest
in a Hurry
     Home      Submit Article      Trainer Registration      Contact Us      Our Mission      Disclaimer      Forums      Public Health Issues      Article Archive      Fitness Links      FEATURED EDITOR'S PICKSNew!      Synergy Performance HealthNew!
 

 
 

Search our Site:
Search Google:
This search box will exclusively search relevant sites that we respect.

( Botulinum toxin) ?

?(US)

Between 1817 and 1822 the German physician and poet Justinus Kerner described botulinium toxin, using the terms "sausage poison" and "fatty poison"[2], as this bacterium often causes poisoning by growing in badly handled or prepared meat products. He first conceived a possible therapeutic use of botulinium toxin. In 1870, Muller (another German physician) coined the name botulism, from Latin botulus = "sausage". In 1895, Emile van Ermengem first isolated the bacterium Clostridium botulinum. In 1944, Edward Schantz cultured Clostridium botulinum and isolated the toxin, and, in 1949, Burgen's group discovered that botulinum toxin blocks neuromuscular transmission.

By 1973, Alan B Scott, MD, of Smith-Kettlewell Institute used botulinium toxin type A (BTX-A) in monkey experiments, and, in 1980, he officially used BTX-A for the first time in humans to treat strabismus. In December 1989, BTX-A (BOTOX) was approved by the US Food and Drug Administration (FDA) for the treatment of strabismus, blepharospasm, and hemifacial spasm in patients over 12 years old. The cosmetic effect of BTX-A was initially described by ophthalmologist Jean Carruthers and dermatologist Alastair Carruthers, a husband-and-wife team working in Vancouver, Canada, although the effect had been observed by a number of independent groups. On April 15, 2002, the FDA announced the approval of botulinum toxin type A (BOTOX Cosmetic) to temporarily improve the appearance of moderate-to-severe frown lines between the eyebrows (glabellar lines). BTX-A has also been approved for the treatment of excessive underarm sweating. The acceptance of BTX-A use for the treatment of spasticity and muscle pain disorders is growing, with approvals pending in many European countries and studies on headaches (including migraine), prostatic symptoms, asthma, obesity and many other possible indications are ongoing.

Botulinum toxin Subcategories

Botulinum toxin Articles

Anti-Aging Wrinkle Control - Do Anti-Aging Eye and Wrinkle Creams Really Work? by Danny Nicholas
Many have taken steps early in life to start combating the process of natural aging and have worked to maintain the same youthful appearance they had in their younger years. Anti-aging eye creams, as well as anti-wrinkle care products have proven to ...

AddThis Social Bookmark Button

 
 Forum Login 
Username:

Password:


Forgot your password?
Register for Forums

Enter your Email!
Sign up for our Senior Fitness Weekly Newletter.
Email:

Suggested Reading from Senior Fitness

Longevity & Fitness - Staying Young in Mind & Body.

Exercise focus for Seniors:

Gary Null, Ph.D. knows as much about aging powerfully as anyone on earth. His new book sums it all up.